联合化疗联合或不联合 Blinatumomab 治疗新诊断 BCR-ABL 阴性 B 系急性淋巴细胞白血病患者
Blinatumomab 用于成人新诊断 BCR-ABL 阴性 B 系急性淋巴细胞白血病的 III 期随机试验
This randomized phase III trial studies combination chemotherapy with blinatumomab to see how well it works compared to induction chemotherapy alone in treating patients with newly diagnosed breakpoint cluster region (BCR)-c-abl oncogene 1, non-receptor tyrosine kinase (ABL)-negative B lineage acute lymphoblastic leukemia. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as blinatumomab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. It is not yet known whether combination chemotherapy is more effective with or without blinatumomab in treating newly diagnosed acute lymphoblastic leukemia.
研究概览
地位
干预/治疗
- 药品:Cyclophosphamide
- 药品:Prednisone
- 程序:Bone Marrow Biopsy
- 程序:Biospecimen Collection
- 生物:Rituximab
- 药品:Vincristine
- 药品:Vincristine Sulfate
- 药品:Dexamethasone
- 程序:Allogeneic Hematopoietic Stem Cell Transplantation
- 生物:Blinatumomab
- 程序:Bone Marrow Aspiration
- 药品:Cytarabine
- 药品:Daunorubicin
- 药品:Daunorubicin Hydrochloride
- 药品:Etoposide
- 药品:Leucovorin Calcium
- 程序:Lumbar Puncture
- 药品:Mercaptopurine
- 药品:Methotrexate
- 药品:Pegaspargase
- 程序:X-Ray Imaging
详细说明
PRIMARY OBJECTIVE:
I. To compare the overall survival (OS) of blinatumomab in conjunction with chemotherapy to chemotherapy alone in patients with BCR-ABL-negative B cell precursor acute lymphoblastic leukemia (ALL) who are minimal residual disease (MRD) negative after induction and intensification chemotherapy, based on multiparameter flow cytometric (MFC) assessment of residual blasts.
SECONDARY OBJECTIVES:
I. To compare the relapse-free survival (RFS) of blinatumomab in conjunction with chemotherapy to chemotherapy alone in MRD negative patients after induction and intensification chemotherapy.
II. To compare the OS and RFS of those patients who are MRD positive (+) at step 3 randomization/registration and then convert to MRD negative (-) after 2 cycles of blinatumomab to those patients who are MRD- at randomization and remain MRD- after 2 cycles of blinatumomab or consolidation chemotherapy.
III. To assess the toxicities of blinatumomab in this patient population. IV. To assess the toxicities of the modified E2993 chemotherapy regimen in this patient population.
V. To describe the outcome of patients who proceed to allogeneic blood or marrow transplant after treatment with or without blinatumomab.
LABORATORY OBJECTIVES:
I. To determine differences in MRD kinetics among patients with the BCR/ABL1-like B-lineage ALL, and to compare the OS (and RFS) of patients with BCR-ABL-like phenotype with those without BCR-ABL-like phenotype.
II. To evaluate the incidence of anti-blinatumomab antibody formation.
OUTLINE:
INDUCTION CHEMOTHERAPY: Patients receive cytarabine intrathecally (IT) on day 1; daunorubicin hydrochloride intravenously (IV) over 10-15 minutes on days 1, 8, 15, and 22; vincristine sulfate IV on days 1, 8, 15, and 22; dexamethasone orally (PO) daily on days 1-7 (and 15-21 for patients age < 55 years only); methotrexate IT on day 14; pegaspargase intramuscularly (IM) or IV on day 18 (patients age < 55 years); and CD20 positive patients may optionally receive rituximab IV on day 8 and 15. Beginning on day 29, patients with absolute neutrophil count (ANC) >= 0.75 x 10^9/L and platelets > 75 x 10^9/L (patients with delayed hematologic recovery) (patients with residual disease that is delaying count begin treatment immediately) receive cyclophosphamide IV over 30 minutes on days 1 and 29, cytarabine IV over 30 minutes or subcutaneously (SC) on days 1-4, 8-11, 29-32, and 36-39, mercaptopurine PO on days 1-14, 29-42, pegaspargase IM or IV on day 15 (patients age < 55 years), patients receiving treatment for central nervous system (CNS) 2 or 3 leukemia in cycle 1 receive methotrexate IT on days 1, 8, 15, and 22, and CD20 positive patients may optionally receive rituximab IV on days 8 and 15.
INTENSIFICATION THERAPY: Beginning 4 weeks after the completion of cycle 2 of induction therapy, patients receive intensification therapy comprising high-dose methotrexate IV over 2 hours on days 1 and 8, and pegaspargase IM or IV on day 9.
Patients are then randomized to 1 of 2 treatment arms.
Patients randomized to the blinatumomab group receive blinatumomab IV continuously on days 1-28. Treatment repeats every 6 weeks for 2 cycles in the absence of disease progression or unacceptable toxicity. Patients may then undergo allogeneic stem cell transplant (SCT) or proceed to consolidation therapy per investigator discretion.
CONSOLIDATION THERAPY: Beginning after the second cycle of blinatumomab (patients randomized to the blinatumomab group) or after intensification therapy (patients not randomized to blinatumomab), patients receive cytarabine IV over 30 minutes or SC on days 1-5, etoposide IV over 1 hour on days 1-5, methotrexate IT on day 1, and pegaspargase IM or IV on day 5, and CD20 positive patients may optionally receive rituximab IV on day 5. Beginning 4 weeks from day 1 of cycle 1, patients receive cytarabine, etoposide, methotrexate, and CD20 positive patients may receive rituximab as in cycle 1. Beginning 4 weeks from day 1 of cycle 2, patients receive daunorubicin hydrochloride IV over 10-15 minutes on day 1, 8, 15, and 22; vincristine sulfate IV on days 1, 8, 15, and 22; dexamethasone PO daily on days 1-7 (and 15-21 for patients age < 55 years); methotrexate IT on day 2; cyclophosphamide IV over 30 minutes on day 29; cytarabine IV over 30 minutes or SC on days 30-33 and 37-40; mercaptopurine PO on days 29-42 and CD20 positive patients may receive rituximab on day 8. Beginning 8 weeks from day 1 of cycle 3, patients receive cytarabine, etoposide, methotrexate, and CD20 positive patients may optionally receive rituximab as in cycle 1. Patients randomized to blinatumomab repeat cycle 4 and then receive blinatumomab IV continuously on days 1-28.
MAINTENANCE THERAPY: Within 6 weeks after beginning last cycle of consolidation therapy, patients receive mercaptopurine PO daily, methotrexate PO or IV over 2 hours once weekly for 2.5 years, vincristine sulfate IV on day 1 every 3 months, prednisone PO on days 1-5 every 3 months, and methotrexate IT on day 1 every 3 months. Treatment continues for up to 2.5 years in the absence of disease progression or unacceptable toxicity.
Patients undergo x-ray imaging during screening, lumbar puncture while on study, and bone marrow aspiration, bone marrow biopsy, and blood sample collection throughout the study.
After completion of study treatment, patients are followed up every 3 months for 2 years, every 6 months for 3 years, and then every 12 months for 5 years.
研究类型
注册 (实际的)
阶段
- 第三阶段
联系人和位置
学习地点
-
-
-
Haifa、以色列、31096
- Rambam Medical Center
-
Jerusalem、以色列、91031
- Shaare Zedek Medical Center
-
-
-
-
Alberta
-
Calgary、Alberta、加拿大、T2N 5G2
- Arthur J E Child Comprehensive Cancer Centre
-
-
British Columbia
-
Vancouver、British Columbia、加拿大、V5Z 3P1
- Clinical Research Unit at Vancouver Coastal Health Authority
-
-
Nova Scotia
-
Halifax、Nova Scotia、加拿大、B3H 2Y9
- QEII Health Sciences Centre/Nova Scotia Health Authority
-
-
Ontario
-
Kingston、Ontario、加拿大、K7L 2V7
- Kingston Health Sciences Centre
-
-
Quebec
-
Montreal、Quebec、加拿大、H1T 2M4
- CIUSSSEMTL-Hopital Maisonneuve-Rosemont
-
-
Saskatchewan
-
Regina、Saskatchewan、加拿大、S4T 7T1
- Allan Blair Cancer Centre
-
-
-
-
-
Bayamón、波多黎各、00959-5060
- Cancer Center-Metro Medical Center Bayamon
-
Manati、波多黎各、00674
- Doctors Cancer Center
-
San Juan、波多黎各、00917
- San Juan Community Oncology Group
-
San Juan、波多黎各、00927
- Centro Comprensivo de Cancer de UPR
-
San Juan、波多黎各、00936
- San Juan City Hospital
-
-
-
-
Alabama
-
Birmingham、Alabama、美国、35233
- University of Alabama at Birmingham Cancer Center
-
-
Alaska
-
Anchorage、Alaska、美国、98508
- Anchorage Associates in Radiation Medicine
-
Anchorage、Alaska、美国、99508
- Alaska Breast Care and Surgery LLC
-
Anchorage、Alaska、美国、99508
- Alaska Oncology and Hematology LLC
-
Anchorage、Alaska、美国、99508
- Alaska Women's Cancer Care
-
Anchorage、Alaska、美国、99508
- Anchorage Oncology Centre
-
Anchorage、Alaska、美国、99508
- Katmai Oncology Group
-
Anchorage、Alaska、美国、99508
- Providence Alaska Medical Center
-
Anchorage、Alaska、美国、99504
- Anchorage Radiation Therapy Center
-
Anchorage、Alaska、美国、99508
- Alaska Regional Hospital
-
Fairbanks、Alaska、美国、99701
- Fairbanks Memorial Hospital
-
-
Arizona
-
Kingman、Arizona、美国、86401
- Kingman Regional Medical Center
-
Tucson、Arizona、美国、85719
- Banner University Medical Center - Tucson
-
Tucson、Arizona、美国、85719
- University of Arizona Cancer Center-North Campus
-
-
Arkansas
-
Fort Smith、Arkansas、美国、72903
- Mercy Hospital Fort Smith
-
Little Rock、Arkansas、美国、72205
- University of Arkansas for Medical Sciences
-
-
California
-
Arroyo Grande、California、美国、93420
- PCR Oncology
-
Burbank、California、美国、91505
- Providence Saint Joseph Medical Center/Disney Family Cancer Center
-
Clovis、California、美国、93611
- Community Cancer Institute
-
Clovis、California、美国、93611
- University Oncology Associates
-
La Jolla、California、美国、92093
- UC San Diego Moores Cancer Center
-
Orange、California、美国、92868
- UC Irvine Health/Chao Family Comprehensive Cancer Center
-
Palo Alto、California、美国、94304
- Stanford Cancer Institute Palo Alto
-
-
Colorado
-
Aurora、Colorado、美国、80012
- Rocky Mountain Cancer Centers-Aurora
-
Aurora、Colorado、美国、80012
- The Medical Center of Aurora
-
Boulder、Colorado、美国、80303
- Boulder Community Foothills Hospital
-
Boulder、Colorado、美国、80304
- Rocky Mountain Cancer Centers-Boulder
-
Denver、Colorado、美国、80218
- Presbyterian - Saint Lukes Medical Center - Health One
-
Denver、Colorado、美国、80220
- Rose Medical Center
-
Denver、Colorado、美国、80218
- Rocky Mountain Cancer Centers-Midtown
-
Denver、Colorado、美国、80220
- Rocky Mountain Cancer Centers-Rose
-
Denver、Colorado、美国、80218
- Colorado Blood Cancer Institute
-
Denver、Colorado、美国、80204
- Cancer Center of Colorado at Sloan's Lake
-
Denver、Colorado、美国、80209
- The Women's Imaging Center
-
Denver、Colorado、美国、80206
- National Jewish Health-Main Campus
-
Denver、Colorado、美国、80220
- Western Surgical Care
-
Denver、Colorado、美国、80218
- Saint Joseph Hospital - Cancer Centers of Colorado
-
Englewood、Colorado、美国、80113
- Mountain Blue Cancer Care Center - Swedish
-
Englewood、Colorado、美国、80113
- Swedish Medical Center
-
Golden、Colorado、美国、80401
- National Jewish Health-Western Hematology Oncology
-
Grand Junction、Colorado、美国、81501
- Saint Mary's Hospital and Regional Medical Center
-
Grand Junction、Colorado、美国、81505
- Grand Valley Oncology
-
Greeley、Colorado、美国、80631
- Banner North Colorado Medical Center
-
Lafayette、Colorado、美国、80026
- Good Samaritan Hospital - Cancer Centers of Colorado
-
Littleton、Colorado、美国、80120
- Rocky Mountain Cancer Centers-Littleton
-
Lone Tree、Colorado、美国、80124
- Sky Ridge Medical Center
-
Lone Tree、Colorado、美国、80124
- Rocky Mountain Cancer Centers-Sky Ridge
-
Loveland、Colorado、美国、80539
- Banner North Colorado Medical Center - Loveland Campus
-
Thornton、Colorado、美国、80260
- National Jewish Health-Northern Hematology Oncology
-
Wheat Ridge、Colorado、美国、80401
- Intermountain Health Lutheran Hospital
-
-
Connecticut
-
Hartford、Connecticut、美国、06105
- Smilow Cancer Hospital Care Center at Saint Francis
-
New Haven、Connecticut、美国、06520
- Yale University
-
Torrington、Connecticut、美国、06790
- Smilow Cancer Hospital-Torrington Care Center
-
-
District of Columbia
-
Washington D.C.、District of Columbia、美国、20016
- Sibley Memorial Hospital
-
-
Florida
-
Coral Springs、Florida、美国、33065
- UM Sylvester Comprehensive Cancer Center at Coral Springs
-
Deerfield Beach、Florida、美国、33442
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach
-
Hollywood、Florida、美国、33021
- UM Sylvester Comprehensive Cancer Center at Hollywood
-
Jacksonville、Florida、美国、32207
- Baptist MD Anderson Cancer Center
-
Miami、Florida、美国、33136
- University of Miami Miller School of Medicine-Sylvester Cancer Center
-
Miami、Florida、美国、33176
- UM Sylvester Comprehensive Cancer Center at Kendall
-
Plantation、Florida、美国、33324
- UM Sylvester Comprehensive Cancer Center at Plantation
-
Weston、Florida、美国、33331
- Cleveland Clinic-Weston
-
-
Georgia
-
Atlanta、Georgia、美国、30322
- Emory University Hospital/Winship Cancer Institute
-
Atlanta、Georgia、美国、30342
- Northside Hospital
-
-
Idaho
-
Boise、Idaho、美国、83706
- Saint Alphonsus Cancer Care Center-Boise
-
Boise、Idaho、美国、83712
- Saint Luke's Cancer Institute - Boise
-
Caldwell、Idaho、美国、83605
- Saint Alphonsus Cancer Care Center-Caldwell
-
Coeur d'Alene、Idaho、美国、83814
- Kootenai Health - Coeur d'Alene
-
Emmett、Idaho、美国、83617
- Walter Knox Memorial Hospital
-
Fruitland、Idaho、美国、83619
- Saint Luke's Cancer Institute - Fruitland
-
Meridian、Idaho、美国、83642
- Idaho Urologic Institute-Meridian
-
Meridian、Idaho、美国、83642
- Saint Luke's Cancer Institute - Meridian
-
Nampa、Idaho、美国、83687
- Saint Alphonsus Cancer Care Center-Nampa
-
Nampa、Idaho、美国、83687
- Saint Luke's Cancer Institute - Nampa
-
Post Falls、Idaho、美国、83854
- Kootenai Clinic Cancer Services - Post Falls
-
Sandpoint、Idaho、美国、83864
- Kootenai Clinic Cancer Services - Sandpoint
-
Twin Falls、Idaho、美国、83301
- Saint Luke's Cancer Institute - Twin Falls
-
-
Illinois
-
Bloomington、Illinois、美国、61704
- Illinois CancerCare-Bloomington
-
Bloomington、Illinois、美国、61701
- OSF Saint Joseph Medical Center
-
Canton、Illinois、美国、61520
- Illinois CancerCare-Canton
-
Carbondale、Illinois、美国、62902
- Memorial Hospital of Carbondale
-
Carterville、Illinois、美国、62918
- SIH Cancer Institute
-
Carthage、Illinois、美国、62321
- Illinois CancerCare-Carthage
-
Centralia、Illinois、美国、62801
- Centralia Oncology Clinic
-
Chicago、Illinois、美国、60611
- Northwestern University
-
Chicago、Illinois、美国、60637
- University of Chicago Comprehensive Cancer Center
-
Chicago、Illinois、美国、60612
- University of Illinois
-
Chicago、Illinois、美国、60608
- Mount Sinai Hospital Medical Center
-
Decatur、Illinois、美国、62526
- Decatur Memorial Hospital
-
Decatur、Illinois、美国、62526
- Cancer Care Specialists of Illinois - Decatur
-
Dixon、Illinois、美国、61021
- Illinois CancerCare-Dixon
-
Effingham、Illinois、美国、62401
- Crossroads Cancer Center
-
Eureka、Illinois、美国、61530
- Illinois CancerCare-Eureka
-
Evanston、Illinois、美国、60201
- NorthShore University HealthSystem-Evanston Hospital
-
Galesburg、Illinois、美国、61401
- Western Illinois Cancer Treatment Center
-
Galesburg、Illinois、美国、61401
- Illinois CancerCare-Galesburg
-
Glenview、Illinois、美国、60026
- NorthShore University HealthSystem-Glenbrook Hospital
-
Highland Park、Illinois、美国、60035
- NorthShore University HealthSystem-Highland Park Hospital
-
Highland Park、Illinois、美国、60035
- Hematology Oncology Associates of Illinois-Highland Park
-
Kankakee、Illinois、美国、60901
- Presence Saint Mary's Hospital
-
Kewanee、Illinois、美国、61443
- Illinois CancerCare-Kewanee Clinic
-
Libertyville、Illinois、美国、60048
- AMG Libertyville - Oncology
-
Macomb、Illinois、美国、61455
- Illinois CancerCare-Macomb
-
Maywood、Illinois、美国、60153
- Loyola University Medical Center
-
Mount Vernon、Illinois、美国、62864
- SSM Health Good Samaritan
-
Niles、Illinois、美国、60714
- Illinois Cancer Specialists-Niles
-
O'Fallon、Illinois、美国、62269
- Cancer Care Center of O'Fallon
-
Ottawa、Illinois、美国、61350
- Illinois CancerCare-Ottawa Clinic
-
Ottawa、Illinois、美国、61350
- Radiation Oncology of Northern Illinois
-
Pekin、Illinois、美国、61554
- Illinois CancerCare-Pekin
-
Pekin、Illinois、美国、61554
- OSF Saint Francis Radiation Oncology at Pekin
-
Peoria、Illinois、美国、61636
- Methodist Medical Center of Illinois
-
Peoria、Illinois、美国、61637
- OSF Saint Francis Medical Center
-
Peoria、Illinois、美国、61615
- Illinois CancerCare-Peoria
-
Peoria、Illinois、美国、61615
- OSF Saint Francis Radiation Oncology at Peoria Cancer Center
-
Peru、Illinois、美国、61354
- Illinois CancerCare-Peru
-
Peru、Illinois、美国、61354
- Valley Radiation Oncology
-
Princeton、Illinois、美国、61356
- Illinois CancerCare-Princeton
-
Skokie、Illinois、美国、60076
- Hematology Oncology Associates of Illinois - Skokie
-
Skokie、Illinois、美国、60076
- North Shore Medical Center
-
Springfield、Illinois、美国、62702
- Southern Illinois University School of Medicine
-
Springfield、Illinois、美国、62702
- Springfield Clinic
-
Springfield、Illinois、美国、62702
- Central Illinois Hematology Oncology Center
-
Springfield、Illinois、美国、62781
- Springfield Memorial Hospital
-
Swansea、Illinois、美国、62226
- Southwest Illinois Health Services LLP
-
-
Indiana
-
Fort Wayne、Indiana、美国、46805
- Parkview Hospital Randallia
-
Fort Wayne、Indiana、美国、46845
- Parkview Regional Medical Center
-
Indianapolis、Indiana、美国、46237
- Franciscan Health Indianapolis
-
Mooresville、Indiana、美国、46158
- Franciscan Health Mooresville
-
Richmond、Indiana、美国、47374
- Reid Health
-
-
Iowa
-
Ames、Iowa、美国、50010
- Mary Greeley Medical Center
-
Ames、Iowa、美国、50010
- McFarland Clinic - Ames
-
Boone、Iowa、美国、50036
- McFarland Clinic - Boone
-
Fort Dodge、Iowa、美国、50501
- McFarland Clinic - Trinity Cancer Center
-
Jefferson、Iowa、美国、50129
- McFarland Clinic - Jefferson
-
Marshalltown、Iowa、美国、50158
- McFarland Clinic - Marshalltown
-
-
Kansas
-
Chanute、Kansas、美国、66720
- Cancer Center of Kansas - Chanute
-
Dodge City、Kansas、美国、67801
- Cancer Center of Kansas - Dodge City
-
El Dorado、Kansas、美国、67042
- Cancer Center of Kansas - El Dorado
-
Fort Scott、Kansas、美国、66701
- Cancer Center of Kansas - Fort Scott
-
Garden City、Kansas、美国、67846
- Central Care Cancer Center - Garden City
-
Great Bend、Kansas、美国、67530
- Central Care Cancer Center - Great Bend
-
Independence、Kansas、美国、67301
- Cancer Center of Kansas-Independence
-
Kansas City、Kansas、美国、66160
- University of Kansas Cancer Center
-
Kingman、Kansas、美国、67068
- Cancer Center of Kansas-Kingman
-
Lawrence、Kansas、美国、66044
- Lawrence Memorial Hospital
-
Lenexa、Kansas、美国、66219
- Kansas Institute of Medicine Cancer and Blood Center
-
Lenexa、Kansas、美国、66219
- Minimally Invasive Surgery Hospital
-
Liberal、Kansas、美国、67905
- Cancer Center of Kansas-Liberal
-
Manhattan、Kansas、美国、66502
- Cancer Center of Kansas-Manhattan
-
McPherson、Kansas、美国、67460
- Cancer Center of Kansas - McPherson
-
Newton、Kansas、美国、67114
- Cancer Center of Kansas - Newton
-
Olathe、Kansas、美国、66061
- The University of Kansas Cancer Center - Olathe
-
Overland Park、Kansas、美国、66209
- Menorah Medical Center
-
Overland Park、Kansas、美国、66213
- Saint Luke's South Hospital
-
Parsons、Kansas、美国、67357
- Cancer Center of Kansas - Parsons
-
Pratt、Kansas、美国、67124
- Cancer Center of Kansas - Pratt
-
Salina、Kansas、美国、67401
- Cancer Center of Kansas - Salina
-
Wellington、Kansas、美国、67152
- Cancer Center of Kansas - Wellington
-
Westwood、Kansas、美国、66205
- University of Kansas Hospital-Westwood Cancer Center
-
Wichita、Kansas、美国、67214
- Ascension Via Christi Hospitals Wichita
-
Wichita、Kansas、美国、67208
- Cancer Center of Kansas-Wichita Medical Arts Tower
-
Wichita、Kansas、美国、67214
- Cancer Center of Kansas - Wichita
-
Wichita、Kansas、美国、67208
- Associates In Womens Health
-
Wichita、Kansas、美国、67214
- Wesley Medical Center
-
Winfield、Kansas、美国、67156
- Cancer Center of Kansas - Winfield
-
-
Kentucky
-
Crestview Hills、Kentucky、美国、41017
- Oncology Hematology Care Inc-Crestview
-
Louisville、Kentucky、美国、40202
- The James Graham Brown Cancer Center at University of Louisville
-
-
Louisiana
-
Baton Rouge、Louisiana、美国、70809
- Ochsner Health Center-Summa
-
Baton Rouge、Louisiana、美国、70816
- Medical Center of Baton Rouge
-
Baton Rouge、Louisiana、美国、70836
- Ochsner High Grove
-
Monroe、Louisiana、美国、71202
- Ochsner LSU Health Monroe Medical Center
-
New Orleans、Louisiana、美国、70121
- Ochsner Medical Center Jefferson
-
Shreveport、Louisiana、美国、71103
- LSU Health Sciences Center at Shreveport
-
-
Maine
-
Bangor、Maine、美国、04401
- Eastern Maine Medical Center
-
Brewer、Maine、美国、04412
- Lafayette Family Cancer Center-EMMC
-
-
Maryland
-
Baltimore、Maryland、美国、21287
- Johns Hopkins University/Sidney Kimmel Cancer Center
-
Baltimore、Maryland、美国、21201
- University of Maryland/Greenebaum Cancer Center
-
Bethesda、Maryland、美国、20889-5600
- Walter Reed National Military Medical Center
-
-
Massachusetts
-
Boston、Massachusetts、美国、02215
- Beth Israel Deaconess Medical Center
-
Boston、Massachusetts、美国、02215
- Dana-Farber Cancer Institute
-
Boston、Massachusetts、美国、02114
- Massachusetts General Hospital Cancer Center
-
-
Michigan
-
Adrian、Michigan、美国、49221
- Bixby Medical Center
-
Adrian、Michigan、美国、49221
- Hickman Cancer Center
-
Ann Arbor、Michigan、美国、48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Battle Creek、Michigan、美国、49017
- Bronson Battle Creek
-
Brownstown、Michigan、美国、48183
- Henry Ford Cancer Institute-Downriver
-
Clinton Township、Michigan、美国、48038
- Henry Ford Macomb Hospital-Clinton Township
-
Dearborn、Michigan、美国、48126
- Henry Ford Medical Center-Fairlane
-
Dearborn、Michigan、美国、48124
- Corewell Health Dearborn Hospital
-
Detroit、Michigan、美国、48202
- Henry Ford Hospital
-
Detroit、Michigan、美国、48201
- Wayne State University/Karmanos Cancer Institute
-
Detroit、Michigan、美国、48236
- Henry Ford Health Saint John Hospital
-
Escanaba、Michigan、美国、49829
- OSF Saint Francis Hospital and Medical Group
-
Farmington Hills、Michigan、美国、48334
- Weisberg Cancer Treatment Center
-
Farmington Hills、Michigan、美国、48336
- Corewell Health Farmington Hills Hospital
-
Flint、Michigan、美国、48503
- Hurley Medical Center
-
Flint、Michigan、美国、48503
- Genesys Hurley Cancer Institute
-
Grand Rapids、Michigan、美国、49503
- Trinity Health Grand Rapids Hospital
-
Grand Rapids、Michigan、美国、49503
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
-
Grand Rapids、Michigan、美国、49503
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
-
Grosse Pointe、Michigan、美国、48230
- William Beaumont Hospital-Grosse Pointe
-
Jackson、Michigan、美国、49201
- Allegiance Health
-
Kalamazoo、Michigan、美国、49007
- West Michigan Cancer Center
-
Kalamazoo、Michigan、美国、49007
- Bronson Methodist Hospital
-
Kalamazoo、Michigan、美国、49048
- Beacon Kalamazoo
-
Lansing、Michigan、美国、48912
- University of Michigan Health - Sparrow Lansing
-
Livonia、Michigan、美国、48154
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Monroe、Michigan、美国、48162
- Mercy Memorial Hospital
-
Monroe、Michigan、美国、48162
- Toledo Clinic Cancer Centers-Monroe
-
Muskegon、Michigan、美国、49444
- Trinity Health Muskegon Hospital
-
Niles、Michigan、美国、49120
- Corewell Health Lakeland Hospitals - Niles Hospital
-
Norton Shores、Michigan、美国、49444
- Cancer and Hematology Centers of Western Michigan - Norton Shores
-
Novi、Michigan、美国、48377
- Henry Ford Medical Center-Columbus
-
Pontiac、Michigan、美国、48341
- Trinity Health Saint Joseph Mercy Oakland Hospital
-
Port Huron、Michigan、美国、48060
- Lake Huron Medical Center
-
Port Huron、Michigan、美国、48060
- Huron Medical Center PC
-
Reed City、Michigan、美国、49677
- Corewell Health Reed City Hospital
-
Roseville、Michigan、美国、48066
- Michigan Cancer Specialists
-
Royal Oak、Michigan、美国、48073
- Cancer Care Associates PC
-
Royal Oak、Michigan、美国、48073
- Comprehensive Medical Center PLLC
-
Royal Oak、Michigan、美国、48073
- Oakland Medical Group
-
Royal Oak、Michigan、美国、48067
- Oakland Colon Rectal Associates
-
Royal Oak、Michigan、美国、48073
- Hematology Oncology Consultants PC-Royal Oak
-
Royal Oak、Michigan、美国、48073
- Corewell Health William Beaumont University Hospital
-
Saginaw、Michigan、美国、48601
- MyMichigan Medical Center Saginaw
-
Saint Joseph、Michigan、美国、49085
- Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
-
Saint Joseph、Michigan、美国、49085
- Corewell Health Lakeland Hospitals - Saint Joseph Hospital
-
Sterling Heights、Michigan、美国、48312
- Premier Hematology Oncology Care
-
Sterling Heights、Michigan、美国、48314
- Mitchell Folbe MD PC
-
Traverse City、Michigan、美国、49684
- Munson Medical Center
-
Troy、Michigan、美国、48084
- Michigan Institute of Urology-Town Center
-
Troy、Michigan、美国、48085
- Claudia BR Herke MD PC
-
Troy、Michigan、美国、48098
- Hematology Oncology Consultants PC-Troy
-
Troy、Michigan、美国、48085
- Corewell Health Beaumont Troy Hospital
-
Warren、Michigan、美国、48093
- Henry Ford Health Warren Hospital
-
West Bloomfield、Michigan、美国、48322
- Henry Ford West Bloomfield Hospital
-
Wyoming、Michigan、美国、49519
- University of Michigan Health - West
-
-
Minnesota
-
Rochester、Minnesota、美国、55905
- Mayo Clinic in Rochester
-
-
Missouri
-
Ballwin、Missouri、美国、63011
- Mercy Oncology and Hematology - Clayton-Clarkson
-
Bolivar、Missouri、美国、65613
- Central Care Cancer Center - Bolivar
-
Bonne Terre、Missouri、美国、63628
- Parkland Health Center-Bonne Terre
-
Branson、Missouri、美国、65616
- Cox Cancer Center Branson
-
Cape Girardeau、Missouri、美国、63703
- Saint Francis Medical Center
-
Cape Girardeau、Missouri、美国、63703
- Mercy Cancer Center - Cape Girardeau
-
City of Saint Peters、Missouri、美国、63376
- Siteman Cancer Center at Saint Peters Hospital
-
Creve Coeur、Missouri、美国、63141
- Siteman Cancer Center at West County Hospital
-
Farmington、Missouri、美国、63640
- Parkland Health Center - Farmington
-
Independence、Missouri、美国、64057
- Centerpoint Medical Center LLC
-
Jefferson City、Missouri、美国、65109
- MU Health Care Goldschmidt Cancer Center
-
Joplin、Missouri、美国、64804
- Freeman Health System
-
Joplin、Missouri、美国、64804
- Mercy Hospital Joplin
-
Kansas City、Missouri、美国、64111
- Saint Luke's Hospital of Kansas City
-
Kansas City、Missouri、美国、64132
- Research Medical Center
-
Kansas City、Missouri、美国、64118
- Heartland Hematology and Oncology Associates Incorporated
-
Lee's Summit、Missouri、美国、64086
- Saint Luke's East - Lee's Summit
-
Liberty、Missouri、美国、64068
- Liberty Hospital
-
Rolla、Missouri、美国、65401
- Mercy Clinic-Rolla-Cancer and Hematology
-
Rolla、Missouri、美国、65401
- Phelps Health Delbert Day Cancer Institute
-
Saint Joseph、Missouri、美国、64506
- Heartland Regional Medical Center
-
Sainte Genevieve、Missouri、美国、63670
- Sainte Genevieve County Memorial Hospital
-
Springfield、Missouri、美国、65807
- CoxHealth South Hospital
-
Springfield、Missouri、美国、65804
- Mercy Hospital Springfield
-
St Louis、Missouri、美国、63110
- Washington University School of Medicine
-
St Louis、Missouri、美国、63129
- Siteman Cancer Center-South County
-
St Louis、Missouri、美国、63131
- Missouri Baptist Medical Center
-
St Louis、Missouri、美国、63109
- Mercy Infusion Center - Chippewa
-
St Louis、Missouri、美国、63141
- Mercy Hospital Saint Louis
-
St Louis、Missouri、美国、63128
- Mercy Hospital South
-
Sullivan、Missouri、美国、63080
- Missouri Baptist Sullivan Hospital
-
Washington、Missouri、美国、63090
- Mercy Hospital Washington
-
-
Montana
-
Anaconda、Montana、美国、59711
- Community Hospital of Anaconda
-
Billings、Montana、美国、59101
- Billings Clinic Cancer Center
-
Billings、Montana、美国、59101
- Saint Vincent Healthcare
-
Billings、Montana、美国、59102
- Saint Vincent Frontier Cancer Center
-
Bozeman、Montana、美国、59715
- Bozeman Health Deaconess Hospital
-
Butte、Montana、美国、59701
- Saint James Community Hospital and Cancer Treatment Center
-
Great Falls、Montana、美国、59405
- Great Falls Clinic
-
Great Falls、Montana、美国、59405
- Benefis Sletten Cancer Institute
-
Helena、Montana、美国、59601
- Saint Peter's Community Hospital
-
Kalispell、Montana、美国、59901
- Logan Health Medical Center
-
Missoula、Montana、美国、59802
- Saint Patrick Hospital - Community Hospital
-
Missoula、Montana、美国、59804
- Community Medical Center
-
-
Nebraska
-
Bellevue、Nebraska、美国、68123
- Nebraska Medicine-Bellevue
-
Omaha、Nebraska、美国、68198
- University of Nebraska Medical Center
-
Omaha、Nebraska、美国、68118
- Nebraska Medicine-Village Pointe
-
-
Nevada
-
Carson City、Nevada、美国、89703
- Carson Tahoe Regional Medical Center
-
Henderson、Nevada、美国、89052
- Comprehensive Cancer Centers of Nevada - Henderson
-
Henderson、Nevada、美国、89052
- Cancer and Blood Specialists-Henderson
-
Henderson、Nevada、美国、89052
- Las Vegas Cancer Center-Henderson
-
Henderson、Nevada、美国、89074
- Comprehensive Cancer Centers of Nevada-Southeast Henderson
-
Henderson、Nevada、美国、89052
- Comprehensive Cancer Centers of Nevada-Horizon Ridge
-
Henderson、Nevada、美国、89074
- Las Vegas Urology - Green Valley
-
Henderson、Nevada、美国、89074
- Las Vegas Urology - Pebble
-
Henderson、Nevada、美国、89074
- Urology Specialists of Nevada - Green Valley
-
Henderson、Nevada、美国、89074
- Oncology Las Vegas - Henderson
-
Las Vegas、Nevada、美国、89144
- Summerlin Hospital Medical Center
-
Las Vegas、Nevada、美国、89109
- Sunrise Hospital and Medical Center
-
Las Vegas、Nevada、美国、89102
- OptumCare Cancer Care at Charleston
-
Las Vegas、Nevada、美国、89106
- Radiation Oncology Centers of Nevada Central
-
Las Vegas、Nevada、美国、89119
- Radiation Oncology Centers of Nevada Southeast
-
Las Vegas、Nevada、美国、89128
- Comprehensive Cancer Centers of Nevada - Northwest
-
Las Vegas、Nevada、美国、89128
- OptumCare Cancer Care at MountainView
-
Las Vegas、Nevada、美国、89135
- Alliance for Childhood Diseases/Cure 4 the Kids Foundation
-
Las Vegas、Nevada、美国、89144
- Comprehensive Cancer Centers of Nevada - Town Center
-
Las Vegas、Nevada、美国、89144
- Comprehensive Cancer Centers of Nevada-Summerlin
-
Las Vegas、Nevada、美国、89148
- Comprehensive Cancer Centers of Nevada
-
Las Vegas、Nevada、美国、89169
- Comprehensive Cancer Centers of Nevada - Central Valley
-
Las Vegas、Nevada、美国、89102
- University Medical Center of Southern Nevada
-
Las Vegas、Nevada、美国、89106
- Cancer and Blood Specialists-Shadow
-
Las Vegas、Nevada、美国、89109
- HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway
-
Las Vegas、Nevada、美国、89113
- HealthCare Partners Medical Group Oncology/Hematology-San Martin
-
Las Vegas、Nevada、美国、89121
- Cancer Therapy and Integrative Medicine
-
Las Vegas、Nevada、美国、89128
- Cancer and Blood Specialists-Tenaya
-
Las Vegas、Nevada、美国、89128
- HealthCare Partners Medical Group Oncology/Hematology-Tenaya
-
Las Vegas、Nevada、美国、89148-2405
- Las Vegas Cancer Center-Medical Center
-
Las Vegas、Nevada、美国、89149
- HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills
-
Las Vegas、Nevada、美国、89128
- Ann M Wierman MD LTD
-
Las Vegas、Nevada、美国、89074
- Las Vegas Urology - Pecos
-
Las Vegas、Nevada、美国、89102
- Desert West Surgery
-
Las Vegas、Nevada、美国、89103
- Hope Cancer Care of Nevada
-
Las Vegas、Nevada、美国、89106
- Urology Specialists of Nevada - Central
-
Las Vegas、Nevada、美国、89113
- Las Vegas Prostate Cancer Center
-
Las Vegas、Nevada、美国、89113
- Las Vegas Urology - Sunset
-
Las Vegas、Nevada、美国、89128
- Las Vegas Urology - Cathedral Rock
-
Las Vegas、Nevada、美国、89128
- Las Vegas Urology - Smoke Ranch
-
Las Vegas、Nevada、美国、89128
- Urology Specialists of Nevada - Northwest
-
Las Vegas、Nevada、美国、89169
- University Cancer Center
-
Las Vegas、Nevada、美国、89113
- Urology Specialists of Nevada - Southwest
-
Las Vegas、Nevada、美国、89128
- Oncology Las Vegas - Tenaya
-
Las Vegas、Nevada、美国、89183
- OptumCare Cancer Care at Fort Apache
-
Pahrump、Nevada、美国、89048
- Hope Cancer Care of Nevada-Pahrump
-
Reno、Nevada、美国、89502
- Renown Regional Medical Center
-
Reno、Nevada、美国、89503
- Saint Mary's Regional Medical Center
-
Reno、Nevada、美国、89509
- Radiation Oncology Associates
-
-
New Hampshire
-
Lebanon、New Hampshire、美国、03756
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
-
-
New Jersey
-
Basking Ridge、New Jersey、美国、07920
- Memorial Sloan Kettering Basking Ridge
-
Middletown、New Jersey、美国、07748
- Memorial Sloan Kettering Monmouth
-
Montvale、New Jersey、美国、07645
- Memorial Sloan Kettering Bergen
-
New Brunswick、New Jersey、美国、08903
- Rutgers Cancer Institute of New Jersey
-
-
New York
-
Buffalo、New York、美国、14263
- Roswell Park Cancer Institute
-
Commack、New York、美国、11725
- Memorial Sloan Kettering Commack
-
Harrison、New York、美国、10604
- Memorial Sloan Kettering Westchester
-
Lake Success、New York、美国、11042
- Northwell Health/Center for Advanced Medicine
-
Manhasset、New York、美国、11030
- North Shore University Hospital
-
New Hyde Park、New York、美国、11040
- Long Island Jewish Medical Center
-
New York、New York、美国、10065
- Memorial Sloan Kettering Cancer Center
-
Rochester、New York、美国、14642
- University of Rochester
-
Stony Brook、New York、美国、11794
- Stony Brook University Medical Center
-
The Bronx、New York、美国、10461
- Montefiore Medical Center-Einstein Campus
-
The Bronx、New York、美国、10467
- Montefiore Medical Center - Moses Campus
-
The Bronx、New York、美国、10461
- Montefiore Medical Center-Weiler Hospital
-
Uniondale、New York、美国、11553
- Memorial Sloan Kettering Nassau
-
-
North Carolina
-
Asheville、North Carolina、美国、28803
- AdventHealth Infusion Center Asheville
-
Chapel Hill、North Carolina、美国、27599
- UNC Lineberger Comprehensive Cancer Center
-
Clyde、North Carolina、美国、28721
- AdventHealth Infusion Center Haywood
-
Hendersonville、North Carolina、美国、28792
- AdventHealth Hendersonville
-
Winston-Salem、North Carolina、美国、27157
- Wake Forest University Health Sciences
-
-
Ohio
-
Beavercreek、Ohio、美国、45431
- Indu and Raj Soin Medical Center
-
Boardman、Ohio、美国、44512
- Saint Elizabeth Boardman Hospital
-
Bowling Green、Ohio、美国、43402
- Toledo Clinic Cancer Centers-Bowling Green
-
Centerville、Ohio、美国、45459
- Miami Valley Hospital South
-
Centerville、Ohio、美国、45459
- Dayton Physicians LLC-Miami Valley South
-
Cincinnati、Ohio、美国、45219
- University of Cincinnati Cancer Center-UC Medical Center
-
Cincinnati、Ohio、美国、45242
- Oncology Hematology Care Inc-Blue Ash
-
Cincinnati、Ohio、美国、45202
- Oncology Hematology Care Inc-Eden Park
-
Cincinnati、Ohio、美国、45211
- Oncology Hematology Care Inc-Mercy West
-
Cincinnati、Ohio、美国、45230
- Oncology Hematology Care Inc-Anderson
-
Cincinnati、Ohio、美国、45236
- Oncology Hematology Care Inc-Kenwood
-
Cleveland、Ohio、美国、44106
- Case Western Reserve University
-
Cleveland、Ohio、美国、44195
- Cleveland Clinic Foundation
-
Columbus、Ohio、美国、43210
- Ohio State University Comprehensive Cancer Center
-
Dayton、Ohio、美国、45406
- Good Samaritan Hospital - Dayton
-
Dayton、Ohio、美国、45409
- Miami Valley Hospital
-
Dayton、Ohio、美国、45415
- Miami Valley Hospital North
-
Dayton、Ohio、美国、45415
- Dayton Physician LLC - Englewood
-
Fairfield、Ohio、美国、45014
- Oncology Hematology Care Inc-Healthplex
-
Findlay、Ohio、美国、45840
- Blanchard Valley Hospital
-
Findlay、Ohio、美国、45840
- Armes Family Cancer Center
-
Findlay、Ohio、美国、45840
- Orion Cancer Care
-
Franklin、Ohio、美国、45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Franklin、Ohio、美国、45005
- Dayton Physicians LLC-Atrium
-
Greenville、Ohio、美国、45331
- Wayne Hospital
-
Greenville、Ohio、美国、45331
- Dayton Physicians LLC-Wayne
-
Kettering、Ohio、美国、45429
- Kettering Medical Center
-
Kettering、Ohio、美国、45409
- Greater Dayton Cancer Center
-
Kettering、Ohio、美国、45420
- First Dayton Cancer Care
-
Lima、Ohio、美国、45804
- Lima Memorial Hospital
-
Maumee、Ohio、美国、43537
- Toledo Clinic Cancer Centers-Maumee
-
Maumee、Ohio、美国、43537
- Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
-
Middletown、Ohio、美国、45042
- Dayton Physicians LLC-Signal Point
-
Oregon、Ohio、美国、43616
- Saint Charles Hospital
-
Oregon、Ohio、美国、43616
- Toledo Clinic Cancer Centers-Oregon
-
Sidney、Ohio、美国、45365
- Dayton Physicians LLC-Wilson
-
Springfield、Ohio、美国、45504
- Springfield Regional Cancer Center
-
Springfield、Ohio、美国、45504
- Springfield Regional Medical Center
-
Sylvania、Ohio、美国、43560
- ProMedica Flower Hospital
-
Tiffin、Ohio、美国、44883
- Mercy Hospital of Tiffin
-
Toledo、Ohio、美国、43606
- ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital
-
Toledo、Ohio、美国、43623
- Mercy Health - Saint Anne Hospital
-
Toledo、Ohio、美国、43623
- Toledo Clinic Cancer Centers-Toledo
-
Toledo、Ohio、美国、43614
- University of Toledo
-
Toledo、Ohio、美国、43617
- Toledo Community Hospital Oncology Program CCOP
-
Toledo、Ohio、美国、43608
- Mercy Health - Saint Vincent Hospital
-
Troy、Ohio、美国、45373
- Upper Valley Medical Center
-
Troy、Ohio、美国、45373
- Dayton Physicians LLC - Troy
-
Warren、Ohio、美国、44484
- Saint Joseph Warren Hospital
-
Wauseon、Ohio、美国、43567
- Fulton County Health Center
-
West Chester、Ohio、美国、45069
- University of Cincinnati Cancer Center-West Chester
-
Wright-Patterson Air Force Base、Ohio、美国、45433
- Wright-Patterson Medical Center
-
Youngstown、Ohio、美国、44501
- Saint Elizabeth Youngstown Hospital
-
-
Oklahoma
-
Oklahoma City、Oklahoma、美国、73104
- University of Oklahoma Health Sciences Center
-
Oklahoma City、Oklahoma、美国、73120
- Mercy Hospital Oklahoma City
-
-
Oregon
-
Baker City、Oregon、美国、97814
- Saint Alphonsus Cancer Care Center-Baker City
-
Bend、Oregon、美国、97701
- Saint Charles Health System
-
Clackamas、Oregon、美国、97015
- Clackamas Radiation Oncology Center
-
Clackamas、Oregon、美国、97015
- Providence Cancer Institute Clackamas Clinic
-
Coos Bay、Oregon、美国、97420
- Bay Area Hospital
-
Newberg、Oregon、美国、97132
- Providence Newberg Medical Center
-
Ontario、Oregon、美国、97914
- Saint Alphonsus Cancer Care Center-Ontario
-
Oregon City、Oregon、美国、97045
- Providence Willamette Falls Medical Center
-
Portland、Oregon、美国、97213
- Providence Portland Medical Center
-
Portland、Oregon、美国、97225
- Providence Saint Vincent Medical Center
-
Redmond、Oregon、美国、97756
- Saint Charles Health System-Redmond
-
-
Pennsylvania
-
Danville、Pennsylvania、美国、17822
- Geisinger Medical Center
-
Hershey、Pennsylvania、美国、17033-0850
- Penn State Milton S Hershey Medical Center
-
Philadelphia、Pennsylvania、美国、19111
- Fox Chase Cancer Center
-
Philadelphia、Pennsylvania、美国、19107
- Thomas Jefferson University Hospital
-
Philadelphia、Pennsylvania、美国、19104
- University of Pennsylvania/Abramson Cancer Center
-
Pittsburgh、Pennsylvania、美国、15232
- UPMC Hillman Cancer Center
-
Scranton、Pennsylvania、美国、18510
- Community Medical Center
-
-
South Carolina
-
Anderson、South Carolina、美国、29621
- AnMed Health Cancer Center
-
Boiling Springs、South Carolina、美国、29316
- Prisma Health Cancer Institute - Spartanburg
-
Easley、South Carolina、美国、29640
- Prisma Health Cancer Institute - Easley
-
Gaffney、South Carolina、美国、29341
- Gibbs Cancer Center-Gaffney
-
Greenville、South Carolina、美国、29605
- Prisma Health Cancer Institute - Faris
-
Greenville、South Carolina、美国、29607
- Saint Francis Cancer Center
-
Greenville、South Carolina、美国、29615
- Prisma Health Cancer Institute - Eastside
-
Greenville、South Carolina、美国、29605
- Prisma Health Cancer Institute - Butternut
-
Greenville、South Carolina、美国、29601
- Saint Francis Hospital
-
Greenville、South Carolina、美国、29605
- Prisma Health Greenville Memorial Hospital
-
Greenville、South Carolina、美国、29601
- Greenville Health System Cancer Institute-Andrews
-
Greer、South Carolina、美国、29650
- Prisma Health Cancer Institute - Greer
-
Greer、South Carolina、美国、29651
- Gibbs Cancer Center-Pelham
-
Lancaster、South Carolina、美国、29720
- Carolina Blood and Cancer Care Associates PA-Lancaster
-
Rock Hill、South Carolina、美国、29732
- Carolina Blood and Cancer Care Associates PA
-
Seneca、South Carolina、美国、29672
- Prisma Health Cancer Institute - Seneca
-
Spartanburg、South Carolina、美国、29303
- Spartanburg Medical Center
-
-
Tennessee
-
Franklin、Tennessee、美国、37067
- Vanderbilt-Ingram Cancer Center Cool Springs
-
Nashville、Tennessee、美国、37232
- Vanderbilt University/Ingram Cancer Center
-
Nashville、Tennessee、美国、37204
- Vanderbilt Breast Center at One Hundred Oaks
-
-
Texas
-
Dallas、Texas、美国、75235
- Parkland Memorial Hospital
-
Dallas、Texas、美国、75390
- UT Southwestern/Simmons Cancer Center-Dallas
-
Houston、Texas、美国、77030
- Houston Methodist Hospital
-
Houston、Texas、美国、77030
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
-
Houston、Texas、美国、77030
- Ben Taub General Hospital
-
-
Utah
-
American Fork、Utah、美国、84003
- American Fork Hospital / Huntsman Intermountain Cancer Center
-
Cedar City、Utah、美国、84720
- Sandra L Maxwell Cancer Center
-
Farmington、Utah、美国、84025
- Farmington Health Center
-
Logan、Utah、美国、84321
- Logan Regional Hospital
-
Murray、Utah、美国、84107
- Intermountain Medical Center
-
Ogden、Utah、美国、84403
- McKay-Dee Hospital Center
-
Provo、Utah、美国、84604
- Utah Valley Regional Medical Center
-
Riverton、Utah、美国、84065
- Riverton Hospital
-
Salt Lake City、Utah、美国、84112
- Huntsman Cancer Institute/University of Utah
-
Salt Lake City、Utah、美国、84106
- Utah Cancer Specialists-Salt Lake City
-
Salt Lake City、Utah、美国、84143
- LDS Hospital
-
South Jordan、Utah、美国、84009
- South Jordan Health Center
-
St. George、Utah、美国、84770
- Saint George Regional Medical Center
-
-
Virginia
-
Fredericksburg、Virginia、美国、22401
- Fredericksburg Oncology Inc
-
Richmond、Virginia、美国、23235
- VCU Massey Cancer Center at Stony Point
-
Richmond、Virginia、美国、23298
- VCU Massey Comprehensive Cancer Center
-
-
Washington
-
Aberdeen、Washington、美国、98520
- Providence Regional Cancer System-Aberdeen
-
Anacortes、Washington、美国、98221
- Cancer Care Center at Island Hospital
-
Auburn、Washington、美国、98001
- MultiCare Auburn Medical Center
-
Bellevue、Washington、美国、98004
- Overlake Medical Center
-
Bellevue、Washington、美国、98005
- Swedish Cancer Institute-Eastside Oncology Hematology
-
Bellingham、Washington、美国、98225
- PeaceHealth Saint Joseph Medical Center
-
Centralia、Washington、美国、98531
- Providence Regional Cancer System-Centralia
-
Edmonds、Washington、美国、98026
- Swedish Cancer Institute-Edmonds
-
Everett、Washington、美国、98201
- Providence Regional Cancer Partnership
-
Gig Harbor、Washington、美国、98335
- MultiCare Gig Harbor Medical Park
-
Issaquah、Washington、美国、98029
- Swedish Cancer Institute-Issaquah
-
Kennewick、Washington、美国、99336
- Kadlec Clinic Hematology and Oncology
-
Lacey、Washington、美国、98503
- Providence Regional Cancer System-Lacey
-
Longview、Washington、美国、98632
- PeaceHealth Saint John Medical Center
-
Port Townsend、Washington、美国、98368
- Jefferson Healthcare
-
Puyallup、Washington、美国、98372
- MultiCare Good Samaritan Hospital
-
Renton、Washington、美国、98055
- Valley Medical Center
-
Seattle、Washington、美国、98107
- Swedish Medical Center-Ballard Campus
-
Seattle、Washington、美国、98122
- Swedish Medical Center-First Hill
-
Seattle、Washington、美国、98112
- Kaiser Permanente Washington
-
Seattle、Washington、美国、98104
- Minor and James Medical PLLC
-
Seattle、Washington、美国、98104
- Pacific Gynecology Specialists
-
Seattle、Washington、美国、98122-5711
- Swedish Medical Center-Cherry Hill
-
Sedro-Woolley、Washington、美国、98284
- PeaceHealth United General Medical Center
-
Shelton、Washington、美国、98584
- Providence Regional Cancer System-Shelton
-
Spokane、Washington、美国、99218
- Evergreen Hematology and Oncology PS
-
Spokane、Washington、美国、99204
- MultiCare Deaconess Cancer and Blood Specialty Center - Downtown
-
Spokane、Washington、美国、99218
- MultiCare Deaconess Cancer and Blood Specialty Center - North
-
Spokane Valley、Washington、美国、99216
- MultiCare Deaconess Cancer and Blood Specialty Center - Valley
-
Tacoma、Washington、美国、98405
- Mary Bridge Children's Hospital and Health Center
-
Tacoma、Washington、美国、98405
- MultiCare Tacoma General Hospital
-
Vancouver、Washington、美国、98664
- PeaceHealth Southwest Medical Center
-
Walla Walla、Washington、美国、99362
- Providence Saint Mary Regional Cancer Center
-
Yakima、Washington、美国、98902
- North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
-
Yelm、Washington、美国、98597
- Providence Regional Cancer System-Yelm
-
-
Wisconsin
-
Eau Claire、Wisconsin、美国、54701
- Marshfield Medical Center-EC Cancer Center
-
Eau Claire、Wisconsin、美国、54701
- Marshfield Clinic Cancer Center at Sacred Heart
-
Green Bay、Wisconsin、美国、54301
- Saint Vincent Hospital Cancer Center Green Bay
-
Green Bay、Wisconsin、美国、54303
- Saint Vincent Hospital Cancer Center at Saint Mary's
-
La Crosse、Wisconsin、美国、54601
- Gundersen Lutheran Medical Center
-
Madison、Wisconsin、美国、53792
- University of Wisconsin Carbone Cancer Center - University Hospital
-
Manitowoc、Wisconsin、美国、54221
- Holy Family Memorial Hospital
-
Marinette、Wisconsin、美国、54143
- Saint Vincent Hospital Cancer Center at Marinette
-
Marshfield、Wisconsin、美国、54449
- Marshfield Medical Center-Marshfield
-
Marshfield、Wisconsin、美国、54449
- Marshfield Medical Center
-
Milwaukee、Wisconsin、美国、53226
- Medical College of Wisconsin
-
Minocqua、Wisconsin、美国、54548
- Marshfield Medical Center - Minocqua
-
Oconto Falls、Wisconsin、美国、54154
- Saint Vincent Hospital Cancer Center at Oconto Falls
-
Rice Lake、Wisconsin、美国、54868
- Marshfield Medical Center-Rice Lake
-
Sheboygan、Wisconsin、美国、53081
- HSHS Saint Nicholas Hospital
-
Stevens Point、Wisconsin、美国、54482
- Marshfield Medical Center-River Region at Stevens Point
-
Sturgeon Bay、Wisconsin、美国、54235-1495
- Saint Vincent Hospital Cancer Center at Sturgeon Bay
-
Wausau、Wisconsin、美国、54401
- Marshfield Clinic-Wausau Center
-
Weston、Wisconsin、美国、54476
- Marshfield Medical Center - Weston
-
-
Wyoming
-
Casper、Wyoming、美国、82609
- Rocky Mountain Oncology
-
Cheyenne、Wyoming、美国、82001
- Cheyenne Regional Medical Center-West
-
Cody、Wyoming、美国、82414
- Big Horn Basin Cancer Center
-
Cody、Wyoming、美国、82414
- Billings Clinic-Cody
-
Sheridan、Wyoming、美国、82801
- Welch Cancer Center
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
-
PRE-REGISTRATION
-
Diagnostic bone marrow and/or peripheral blood specimens must be submitted for immunophenotyping and selected molecular testing, and the establishment of BCR/ABL status; testing will be performed by the Eastern Cooperative Oncology Group (ECOG)-American College of Radiation Imaging Network (ACRIN) Leukemia Translational Research Laboratory (LTRL) and reported to the institution
- NOTE: IT IS ESSENTIAL THAT A SAMPLE CONTAINING SUFFICIENT BLAST CELLS BE SUBMITTED TO THE ECOG-ACRIN LTRL AT BASELINE SO THAT SUBSEQUENT BONE MARROW ASSESSMENTS OF MRD CAN BE DONE; IN ADDITION TO ALLOWING THE LTRL TO CONFIRM ELIGIBILITY BASED ON BLAST CELL IMMUNOPHENOTYPE AND BCR/ABL STATUS, IT IS ALSO IMPERATIVE THAT AN ADEQUATE NUMBER OF BLASTS BE BANKED FOR ANALYSIS BY DRS MULLIGHAN/WILLMAN. WITHOUT ADEQUATE BASELINE SAMPLES, PATIENTS WILL NOT BE ABLE TO BE TREATED AND RANDOMIZED ON THIS PROTOCOL; IF A BONE MARROW ASPIRATE IS NOT AVAILABLE FOR LTRL SUBMISSION AT BASELINE, IT IS IMPERATIVE THAT DR PAIETTA FROM THE LTRL IS CALLED TO DISCUSS THE PERIPHERAL BLOOD WHITE BLOOD CELL (WBC) AND BLAST COUNT BEFORE BLOOD ONLY IS SUBMITTED
- NOTE: Hydroxyurea can be given for up to 5 days prior to initiation of protocol therapy for control of leukocyte count and/or other symptoms or signs; corticosteroids can be given after pre-registration to the protocol and submission of baseline marrow and blood samples for control of leukocyte count and/or other symptoms or signs prior to initiation of protocol therapy if needed; if corticosteroids are given prior to pre-registration, contact the study chair as the patient may still be eligible to participate
-
INDUCTION ELIGIBILITY CRITERIA-STEP 1
-
Age >= 30 years and =< 70 years
-
New diagnosis of B lineage ALL must be made upon bone marrow or peripheral blood immunophenotyping; cases with myeloid antigen expression, but unequivocal lymphoid immunophenotype, are eligible
-
Negativity for the Philadelphia chromosome must be established by conventional cytogenetics, fluorescence in situ hybridization (FISH) and/or polymerase chain reaction (PCR); patients who are negative for the Philadelphia chromosome by conventional cytogenetics must have FISH or PCR performed for BCR/ABL to exclude occult translocations
-
Cytogenetic analysis must be performed from diagnostic bone marrow (preferred) or if adequate number of circulating blasts from peripheral blood; FISH testing for common B-lineage ALL abnormalities including t(9;22) (BCR/ABL1), t(12;21) (ETS-variant gene 6 [ETV6]/runt-related transcription factor 1 [RUNX1]), t(1;19) (pre-B-cell leukemia homeobox 1 [PBX1]/transcription factor 3 [TCF3]), +4,+10,+17, (centromeric [Cen]4/Cen10/Cen17), t(11q23;var), (myeloid/lymphoid or mixed lineage leukemia [MLL]), deletion (del)(9p) (cyclin-dependent kinase inhibitor 2A [CDKN2A]/Cen9), and t(14;var) (immunoglobulin heavy chain [IGH] is encouraged); if there are few or no circulating blasts and an adequate marrow sample cannot be obtained for cytogenetic analysis, the patient may still enroll on the trial
-
Serum direct bilirubin < 2 mg/dl or serum total bilirubin =< 3 (obtained =< 48 hours prior to registration); NOTE: the above stipulation for normal hepatic function does not apply if liver dysfunction is due to leukemia infiltration
-
Serum creatinine < 2 mg/dl (obtained =< 48 hours prior to registration); NOTE: the above stipulation for normal hepatic function does not apply if liver dysfunction is due to leukemia infiltration
-
Patient should be human leukocyte antigen (HLA) typed (A, B, C, DR and DQ) during induction therapy phase or a written explanation for not undergoing HLA typing on the flow sheet
-
Patients with known human immunodeficiency virus (HIV) infection are eligible if they meet all of the following criteria:
- No history of acquired immune deficiency syndrome (AIDS)-related complications other than a history of low CD4+ T-cell count (< 200/mm^3) prior to initiation of combination antiretroviral therapy; on study CD4+ T-cell count may not be informative due to leukemia and should not be used as an exclusion criterion if low
- Patient must be healthy on the basis of HIV disease with high likelihood of near normal life span were it not for the leukemia
- Patient must have serum HIV viral load of < 200 copies/mm^3
- Patient must be on combination antiretroviral therapy with minimal pharmacokinetic interactions with study therapy and minimal overlapping clinical toxicity with protocol therapy
- Patient must not be receiving protease inhibitors or once daily formulations containing cobicistat, stavudine, or on regimens containing stavudine or zidovudine
- It is recommended to utilize a regimen of the integrase inhibitor, dolutegravir, combined with either disoproxil fumarate/emtricitabine or dolutegravir combined with tenofovir alafenamide/emtricitabine
-
Patient must have no history of recent myocardial infarction (within three months), uncontrolled congestive heart failure, or uncontrolled cardiac arrhythmia
-
Patient must have a normal cardiac ejection fraction by pretreatment multigated acquisition scan (MUGA) or echocardiogram within 4 weeks prior to registration (resting ejection fraction >= 40% or >= 5% increase with exercise), shortening fraction by echocardiogram >= 24%, or to within the normal range of values for the institution
-
Women must not be pregnant or breast-feeding due to administration of teratogenic chemotherapy and must not become pregnant or breastfeed during protocol therapy and for at least 3 months after protocol therapy; woman of childbearing potential must abstain from sexual activity or be willing to use 2 highly effective forms of contraception throughout protocol therapy and for at least an additional 3 months after the last dose of protocol-specified therapy; all females of childbearing potential must have a blood test or urine study within 2 weeks prior to registration to rule out pregnancy; a female of childbearing potential is any woman, regardless of whether they have undergone tubal ligation, who meets the following criteria: has not undergone a hysterectomy or bilateral oophorectomy; or has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)
-
Men who have a female partner of childbearing potential must be willing to use 2 highly effective forms of contraception throughout protocol therapy and for at least an additional 3 months after the last dose of protocol-specified therapy; men who have a pregnant partner must be willing to use a condom during sexual activity throughout protocol therapy and for 3 months after the last dose of protocol-specified therapy
-
ECOG performance score 0-3
-
Patient must have given written informed consent
-
POST-INDUCTION THERAPY ELIGIBILITY CRITERIA (PRIOR TO INTENSIFICATION-STEP 2)
-
ECOG performance status 0-2
-
Patients must have achieved a CR or CRi
-
Patients who have achieved a CR or CRi must have maintained peripheral blood evidence of a CR or CRi
-
Patient must be CNS (cerebrospinal fluid [CSF]) negative for leukemia
-
Patients must have resolved any serious infectious complications related to induction
-
Any significant medical complications related to induction must have resolved
-
Serum creatinine =< 2.0 mg/dl (obtained =< 48 hours prior to registration)
-
Serum direct bilirubin < 2 mg/dL or serum total bilirubin =< 3 (obtained =< 48 hours prior to registration)
-
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) < 3 x upper limit of normal (ULN) (obtained =< 48 hours prior to registration)
-
RANDOMIZATION OR ASSIGNMENT TO BLINATUMOMAB OR NO BLINATUMOMAB-STEP 3
-
Patients must have an ECOG performance status of 0-2
-
Patients must have maintained peripheral blood evidence of a remission and must have a CR or CRi, confirmed on restaging bone marrow (BM) aspirate and biopsy
-
Patients must have resolved any serious infectious complications related to therapy
-
Any significant medical complications related to therapy must have resolved
-
Direct or total bilirubin < 1.5 x ULN (unless related to Gilbert's or Meulengracht's syndrome); the values must be obtained within 48 hours prior to randomization
-
Serum creatinine < 1.5 x ULN; the values must be obtained within 48 hours prior to randomization
-
Bone marrow aspirates must be submitted for centralized minimal residual disease (MRD) assessment performed by the ECOG-ACRIN Leukemia Translational Research Laboratory
-
MRD results will be reported to the submitting institution
-
NOTE: FOR MRD ASSESSMENTS, AN ASPIRATE FROM A SEPARATE BONE MARROW ASPIRATION SITE MUST BE SUBMITTED (THE NEEDLE CAN BE RE-DIRECTED THROUGH THE SAME SKIN PUNCTURE SITE); ONLY SUBMIT ASPIRATES FROM THE FIRST PULL OF AN ASPIRATION SITE FOR MRD TESTING; DO NOT SUBMIT SAMPLES FROM THE SECOND OR THIRD PULL OF THE SAME ASPIRATION SITE
-
In B-lineage ALL, MRD levels in peripheral blood or from a dilute marrow aspiration can be 300% lower, on average, than those in bone marrow at a given time point; submitting a first pull from a separate aspiration site will ensure that MRD determinations used in randomization and trial interpretation are accurate
- NOTE: failure to submit bone marrow aspirates will result in a major violation at the time of an audit
-
-
CRITERIA FOR ALLOGENEIC TRANSPLANTATION
-
A suitable donor must be identified; there are no restrictions on donor type and can include a matched sibling, a matched or mismatched unrelated donor, a family haplotype matched donor or a cord blood donor (single or double)
-
Patients should meet the eligibility criteria for RANDOMIZATION OR ASSIGNMENT TO BLINATUMOMAB OR NO BLINATUMOMAB-STEP 3
-
Patients must be considered reliable enough to comply with the medication regimen and follow-up, and have social support necessary to allow this compliance
-
CRITERIA FOR MAINTENANCE THERAPY-STEP 4: Patients must have an ECOG performance status of 0-3
-
CRITERIA FOR MAINTENANCE THERAPY-STEP 4: Patients must have maintained peripheral blood evidence of a remission and must have a CR or CRi, confirmed on restaging BM aspirate and biopsy
-
CRITERIA FOR MAINTENANCE THERAPY-STEP 4: Patients must have resolved any serious infectious complications related to therapy
-
CRITERIA FOR MAINTENANCE THERAPY-STEP 4: Any significant medical complications related to therapy must have resolved
Exclusion Criteria:
- Mature B ALL (Burkitt's-like leukemia) is excluded from enrollment in this trial; pre-study bone marrow biopsy and aspirate must be completed =< 1 week prior to registration
- Patient must not have a concurrent active malignancy for which they are receiving treatment
- Patient must not have intercurrent organ damage or medical problems that will jeopardize the outcome of therapy (i.e., psychiatric disorder, drug abuse, pregnancy)
- Patient must not have an antecedent hematologic disorder
- Patient must not have a history or presence of clinically relevant central nervous system (CNS) pathology such as epilepsy, seizure, paresis, aphasia, stroke, severe brain injuries, dementia; Parkinson's disease, cerebellar disease, organic brain syndrome, psychosis, or other significant CNS abnormalities
- Patient must not have an active uncontrolled infection
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Arm I (blinatumomab, chemotherapy)
See Detailed Description |
Given IV
其他名称:
Given PO
其他名称:
Undergo bone marrow biopsy
其他名称:
Undergo blood sample collection
其他名称:
Given IV
其他名称:
Given IV
其他名称:
Given IV
其他名称:
Given PO
其他名称:
Undergo allogeneic hematopoietic SCT
其他名称:
Given IV
其他名称:
Undergo bone marrow aspiration Given IT, IV, or SC
其他名称:
Given IV
其他名称:
Given IV
其他名称:
Given IV
其他名称:
Given IV or PO
其他名称:
Undergo lumbar puncture
其他名称:
Given PO
其他名称:
Given PO, IT or IV
其他名称:
Given IM or IV
其他名称:
Undergo x-ray imaging
其他名称:
|
|
有源比较器:Arm II (chemotherapy)
See Detailed Description |
Given IV
其他名称:
Given PO
其他名称:
Undergo bone marrow biopsy
其他名称:
Undergo blood sample collection
其他名称:
Given IV
其他名称:
Given IV
其他名称:
Given IV
其他名称:
Given PO
其他名称:
Undergo allogeneic hematopoietic SCT
其他名称:
Undergo bone marrow aspiration Given IT, IV, or SC
其他名称:
Given IV
其他名称:
Given IV
其他名称:
Given IV
其他名称:
Given IV or PO
其他名称:
Undergo lumbar puncture
其他名称:
Given PO
其他名称:
Given PO, IT or IV
其他名称:
Given IM or IV
其他名称:
Undergo x-ray imaging
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Overall Survival (OS) Among Patients Who Were MRD Negative After Induction and Intensification Chemotherapy
大体时间:Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
Overall survival is defined as the time from randomization to death of any cause. |
Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Relapse-free Survival (RFS) Among Patients Who Were MRD Negative After Induction and Intensification Chemotherapy
大体时间:Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
RFS was defined as time from randomization to relapse or to death without documentation of relapse. Patients without events were censored at the date of last disease assessment. Relapse/Persistent Disease Persistent disease/Relapse following complete remission (CR)/complete remission incomplete (CRi) is defined as:
|
Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
|
RFS Among of Those Who Are MRD+ at Randomization and Then Convert to MRD- After 2 Cycles of Blinatumomab to Those Patients Who Are MRD- at Randomization and Remain MRD- After 2 Cycles of Blinatumomab or Consolidation Chemotherapy
大体时间:Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
RFS was defined as time from end of 2 cycles of blinatumomab to relapse or to death without documentation of relapse. Patients without events were censored at the date of last disease assessment. Relapse/Persistent Disease Persistent disease/Relapse following complete remission (CR)/complete remission incomplete (CRi) is defined as:
|
Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
|
OS Among of Those Who Are MRD+ at Randomization and Then Convert to MRD- After 2 Cycles of Blinatumomab to Those Patients Who Are MRD- at Randomization and Remain MRD- After 2 Cycles of Blinatumomab or Consolidation Chemotherapy
大体时间:Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
OS was defined as time from end of 2 cycles of blinatumomab to death of any cause |
Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
|
OS Among MRD Negative Patients Who Proceed to Allogeneic Transplant on Study
大体时间:Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
OS was defined as time from allogeneic transplant to death of any cause. |
Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
To Determine Differences in MRD Kinetics Among Patients With the BCR/ABL1-like B-lineage ALL, and to Compare the OS (and RFS) of Patients With BCR-ABL-like Phenotype With Those Without BCR-ABLlike Phenotype
大体时间:Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
To determine differences in MRD kinetics among patients with the BCR/ABL1-like B-lineage ALL, and to compare the OS (and RFS) of patients with BCR-ABL-like phenotype with those without BCR-ABLlike phenotype |
Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
|
Incidence of Anti-blinatumomab Antibody Formation
大体时间:Assessed at baseline, end of 2 cycles of blinatumomab, end of 4 cycles of blinatumomab, and end of blinatumomab treatment
|
To evaluate the incidence of anti-blinatumomab antibody formation |
Assessed at baseline, end of 2 cycles of blinatumomab, end of 4 cycles of blinatumomab, and end of blinatumomab treatment
|
合作者和调查者
调查人员
- 首席研究员:Mark R Litzow、ECOG-ACRIN Cancer Research Group
出版物和有用的链接
一般刊物
- Seftel MD. Hyper-CVAD: a regimen for all seasons. Lancet Haematol. 2020 Jul;7(7):e501-e502. doi: 10.1016/S2352-3026(20)30179-4. No abstract available.
- Litzow MR, Sun Z, Mattison RJ, Paietta EM, Roberts KG, Zhang Y, Racevskis J, Lazarus HM, Rowe JM, Arber DA, Wieduwilt MJ, Liedtke M, Bergeron J, Wood BL, Zhao Y, Wu G, Chang TC, Zhang W, Pratz KW, Dinner SN, Frey N, Gore SD, Bhatnagar B, Atallah EL, Uy GL, Jeyakumar D, Lin TL, Willman CL, DeAngelo DJ, Patel SB, Elliott MA, Advani AS, Tzachanis D, Vachhani P, Bhave RR, Sharon E, Little RF, Erba HP, Stone RM, Luger SM, Mullighan CG, Tallman MS. Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults. N Engl J Med. 2024 Jul 25;391(4):320-333. doi: 10.1056/NEJMoa2312948.
- Zhong X, Roberts KG, Wei H, Sun Z, Montefiori LE, Kumar A, Iacobucci I, Baviskar P, Gao Q, Polonen P, Pruett-Miller SM, Schreiber RM, Chang TC, Zhang W, Lei S, Rampersaud E, Fan Y, Wu G, Mattison RJ, Zhang Y, Racevskis J, Lazarus HM, Rowe JM, Arber DA, Wieduwilt MJ, Abou Mourad Y, Shami PJ, Baer MR, Asch AS, O'Dwyer KM, Hall A, Liedtke M, Bergeron J, Wood BL, Pratz KW, Dinner SN, Frey NV, Gore SD, Bhatnagar B, Atallah EL, Uy GL, Jeyakumar D, Lin TL, Willman CL, Podoltsev NA, DeAngelo DJ, Patel S, Elliott MA, Advani AS, Tzachanis D, Vachhani P, Bhave RR, Sharon E, Little RF, Erba HP, Stone RM, Tallman MS, Yang JJ, Luger SM, Paietta E, Litzow MR, Mullighan CG. Genomic drivers of leukemia and blinatumomab response in adult acute lymphoblastic leukemia - the ECOG-ACRIN E1910 study. Blood. 2026 Oct 5:blood.2026033793. doi: 10.1182/blood.2026033793. Online ahead of print.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
- 肿瘤
- 免疫系统疾病
- 感染
- 病毒病
- 组织学类型的肿瘤
- 血液病
- DNA 病毒感染
- 淋巴系统疾病
- 淋巴增生性疾病
- 免疫增生性疾病
- 淋巴瘤,非霍奇金
- 淋巴瘤,B细胞
- 淋巴瘤
- 白血病、淋巴细胞
- 白血病
- 爱泼斯坦-巴尔病毒感染
- 疱疹病毒科感染
- 肿瘤病毒感染
- 半身和淋巴疾病
- 前体细胞淋巴细胞白血病-淋巴瘤
- 伯基特淋巴瘤
- 氨基酸,肽和蛋白质
- 蛋白质
- 硫化合物
- 有机化学品
- 杂环化合物,1形
- 杂环化合物
- 杂环化合物,2环
- 杂环化合物,融合环
- 调查技术
- 疗法
- 临床实验室技术
- 诊断技术和程序
- 诊断
- 穿刺
- 手术程序,手术
- 细胞学技术
- 核酸,核苷酸和核苷
- 细胞诊断
- 碳氢化合物
- 碳氢化合物,循环
- 碳水化合物
- 身体现象
- 生物碱
- Podophyllotoxin
- 四氢乙烯甲烯烃
- 萘
- 多环芳烃
- 碳氢化合物,芳香族
- 多环化合物
- 葡萄糖剂
- 糖苷
- 移植
- 设备和用品
- 酶和辅酶
- 吲哚
- 抗体,单克隆
- 抗体
- 免疫球蛋白
- 免疫蛋白
- 血蛋白
- 血清球蛋白
- 球蛋白
- 嘌呤
- 胞苷
- 嘧啶核苷
- 嘧啶
- 怀孕
- 怀孕
- 类固醇
- 融合环化合物
- 类固醇,氟化
- 苯衍生物
- 诊断技术,手术
- 磺酸
- 硫酸
- 磷酰胺芥末
- 氮芥末化合物
- 芥末化合物
- 碳氢化合物,卤素
- 磷酰胺
- 有机磷化合物
- 核苷
- 甲基四氢胶酸盐
- 四氢胶质
- 叶酸
- 翼
- 翼状
- 疗法
- 妊娠二培养子
- VINCA生物碱
- Secologanin色素生物碱
- 吲哚生物碱
- 吲哚衍生物
- 吲哚王
- 阿拉伯核苷
- 氨基翅目
- 蒽环类动物
- 萘烯
- 氨基糖苷
- 辅酶
- 电磁现象
- 磁现象
- 抗体,单克隆,鼠的衍生
- 细胞移植
- 基于细胞和组织的治疗
- 生物疗法
- 诊断技术,神经系统
- 电磁辐射
- 辐射
- 辐射,电离
- 苯磺酸盐
- 芳基磺酸盐
- 芳基磺酸
- 亚硫烯基化合物
- 利妥昔单抗
- 地塞米松
- 甲氨蝶呤
- 强的松
- 环磷酰胺
- 阿糖胞苷
- 依托泊苷
- 亚叶酸
- 长春新碱
- 柔红霉素
- 巯基嘌呤
- 羟苯磺酸钙
- 活检
- 标本处理
- blinatumomab
- 干细胞移植
- 脊柱穿刺
- 地塞米松21-磷酸盐
- X射线
- CT-P10
- Deltacortene
- prepnylidene
- N,N-二甲苯己基 - 异位醇-10-磺胺酰胺
- 阿扎硫嘌呤
- 铜
- pegaspargase
- 幻影,成像
- 耳原则
- 乙酸地塞米松
其他研究编号
- NCI-2013-02229
- U10CA180820 (美国 NIH 拨款/合同)
- U24CA196172 (美国 NIH 拨款/合同)
- U10CA021115 (美国 NIH 拨款/合同)
- NCI-2013-02229 (注册表标识符:CTRP (Clinical Trial Reporting Program))
- ECOG-E1910
- E1910 (其他标识符:CTEP)
- PE1910_A08PAMDREVW01
- E1910 (其他标识符:ECOG-ACRIN Cancer Research Group)
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.